Health Care & Life Sciences » Pharmaceuticals | Taisho Pharmaceutical Holdings Co. Ltd.

Taisho Pharmaceutical Holdings Co. Ltd. | Ownership

Companies that own Taisho Pharmaceutical Holdings Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
1,078,160
1.2%
8,396
0%
07/31/2018
BlackRock Fund Advisors
1,066,200
1.18%
-300
0.01%
09/06/2018
Nomura Asset Management Co., Ltd.
764,798
0.85%
10,886
0.05%
07/31/2018
Daiwa Asset Management Co. Ltd.
380,600
0.42%
21,300
0.05%
07/31/2018
Nikko Asset Management Co., Ltd.
333,599
0.37%
-101
0.02%
08/20/2018
Norges Bank Investment Management
287,622
0.32%
-436,560
0%
12/31/2017
Brandes Investment Partners LP
203,750
0.23%
-1,900
0.17%
08/31/2018
BlackRock Advisors (UK) Ltd.
181,817
0.2%
200
0.01%
09/06/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
144,500
0.16%
8,900
0.03%
04/09/2018
Geode Capital Management LLC
139,757
0.16%
2,200
0%
09/11/2018

About Taisho Pharmaceutical Holdings Co.

View Profile
Address
3-24-1 Takada
Tokyo Tokyo 170
Japan
Employees -
Website http://www.taisho-holdings.co.jp
Updated 07/08/2019
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.